Commercial Funding Opportunities
The National Multiple Sclerosis Society is committed to accelerating breakthroughs to fuel treatments and solutions that will stop disease progression, restore function, and end multiple sclerosis (MS) forever. As an important part of the Society’s research infrastructure, investments through Fast Forward, the Society’s commercial funding program, will continue to close the gap between promising discoveries and the commercial development necessary to get new treatments to people with MS.
Current funding opportunity:
Therapeutic Development Opportunities for Neuroprotection and Neuroregeneration in Multiple Sclerosis
Details on the current funding opportunity are available to download below. To submit a proposal for Fast Forward support, applicants must first register with our online portal (https://nmss.fluxx.io
) and complete a brief pre-application. Staff will review the pre-application to determine whether the proposed research plan is appropriate and relevant to the objectives of the Request for Proposals (RFP).
Pre-applications will be accepted beginning November 8th, 2017
Final date for acceptance of pre-applications: December 6th, 2017
Final date for receipt of completed full applications: December 20th, 2017
For more information, please contact:
Mark Allegretta, PhD
Associate Vice President, Commercial Research
Director, Business and Partnership Development
Walter Kostich, PhD
Director, Commercial Research